National governments are turning to techniques of economic evaluation such as
cost-effectiveness and cost-benefit analysis for prioritizing alternative treatment
and care strategies among competing effective programs and identifying these best
approaches. This conference will serve as a platform to discuss how economic
evaluation tools can be used to create locally appropriate solutions. Country
government officials, local health economists and top researchers within the
economic evaluation field will convene to address common policy issues and
recommend how economic evaluation can inform policy decisions.

This conference would not be made possible without the support and
partnership of our sponsors:
The Bill and Melinda Gates Foundation
Elizabeth Glaser Pediatric AIDS Foundation
Fogarty International Training Program in AIDS-related Epidemiology (AITRP)
Harvard School of Public Health
Harvard School of Public Health AIDS Initiative
Harvard University Centers for AIDS Research
Harvard University Program on AIDS
Joint United Nations Programme on HIV/AIDS
The Merck Company Foundation
National Institute of Mental Health
World Bank
World Health Organization

Program

Wednesday, September 13, 2006 (See below for shuttle bus information)

5:00 – 7:00PM	Registration
7:00PM	Dinner – Welcome and Opening Remarks by: Barry Bloom, Harvard School of Public Health Joy Phumaphi, World Health Organization, and Richard Marlink, Harvard School of Public Health and Elizabeth Glaser Pediatric AIDS Foundation Location: Boston Harbor Hotel, 70 Rose Wharf

Thursday, September 14, 2006

7:00 – 8:00AM	Breakfast and Registration
8:00 – 8:30AM	Introductions, Purpose of the Meeting and Opening Remarks Richard Marlink, Harvard School of Public Health and Elizabeth Glaser Pediatric AIDS Foundation and Marionette Holmes, Harvard School of Public Health Steven Forsythe, Instituto Nacional de Salud Publica, Mexico Framing the Issues - Using Economic Analysis to Help Guide Priority Setting - Robert Greener, Joint United Nations Programme on HIV/AIDS
8:30 – 10:00AM	Session 1: Economic Analysis and HIV/AIDS Policy: Using Cost Benefit and Cost Effectiveness Analysis to Guide Policy and Priority Setting Chairs: Kenneth Freedberg, Partners AIDS Research Center and Harvard Medical School and Barry Bloom, Harvard School of Public Health Facilitator: Steven Forsythe, Instituto Nacional de Salud Publica, Mexico Overview of the Cost Effectiveness of Preventing AIDS Complication Model: Examining Its Use in Impacting OI Prophylaxis, Genotyping and HAART Therapy Guidelines – Ken Freedberg, Partners AIDS Research Centerand Harvard Medical School Challenges and Advantages to Using Cost Effectiveness and Cost Benefit Information as Evidence for Policy and Programme Changes – Vishal Brijlal, Clinton Foundation HIV/AIDS Initiative, India How Do Donors Determine How to Allocate Available HIV/AIDS Funds Across Countries in Sub-Saharan Africa? – William McGreevey, Constella Futures Using Cost Effectiveness Analysis to Guide Policy and Priority Setting – Gerald Mumma, Prevention Effectiveness and Health Economics Branch, OWCD, Centers for Disease Control Usefulness of CEA to Decision Makers: Approaches in Identifying the Best Mix of Interventions and in Targeting Interventions to Produce Maximum Effect – Stefano Bertozzi, Instituto Nacional de Salud Publica, Mexico
10:00 – 10:15AM	Tea break
10:15AM – 12:00PM	Concurrent Sessions 2 and 3 Session 2: Prevention and Treatment: Synergy, Cost Savings and Consequences Chair: Joseph Sevilla, Harvard School of Public Health Facilitator: Richard Marlink, Harvard School of Public Health and Elizabeth Glaser Pediatric AIDS Foundation Accounting for Behavioral Response in CE Models of the AIDS Epidemic: Examples from India and Thailand – Mead Over, World Bank HIV Prevention and Treatment: Substitutions or Complementarities – Jean-Paul Moatti, Institut National de la Santé et de la Recherche Médicale, France ART and VCT Uptake – Robin Wood, Desmond Tutu HIV Center, South Africa Cost Effectiveness of ART: Taking Prevention Benefits into Account and Its Implications for Prevention and Treatment Policy – Elliot Marseille, Institute for Health Policy Studies, University of California at San Francisco & Considerations in Comparing and Combining Cost Effectiveness Estimates for Prevention and Treatment – James Kahn, Institute for Health Policy Studies, University of California at San Francisco Modeling the Interactions of Prevention and Treatment – Joshua A. Salomon, Harvard University Coming to Terms with Complexity: Spillovers, Increasing Returns, and Health Economics – Eileen Stillwaggon, Gettysburg College Session 3: Business and AIDS: Impact, Interventions and Benefits Chair: Jeffrey Sturchio, Merck & Co., Inc. Facilitator: Anokhi Parikh, Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal, South Africa HIV/AIDS and the Private Sector– Jonathon Simon, Boston University School of Public Health Factors Influencing Costs and Savings to Employers from a Workplace ART Intervention in South Africa – Debbie Muirhead, Aurum Health Research, South Africa Role of Private Sector in Comprehensive Initiatives – Henk Rijckborst, Heineken International, Netherlands The Value of HIV/AIDS Workplace Policies on Companies Responses to HIV/AIDS – Bill Rau, Independent Consultant on HIV/AIDS and Development HIV/AIDS and Business Policies – Klara Tisocki, Kuwait University "AIDS is Everybody's Business": The Role of Partnerships in Scaling Up the Response to HIV/AIDS – Jeffrey Sturchio, Merck & Co., Inc.
12:00 – 1:00PM	Lunch
1:00 – 3:00PM	Concurrent Specialized Sessions: Framing Key Issues and Questions Session A for participants of Prevention and Treatment: Synergy, Cost Savings and Consequences Chair: Bisola Ojikutu, Harvard Medical School Facilitators: Richard Marlink, Harvard School of Public Health and Elizabeth Glaser Pediatric AIDS Foundation and Robert Oelrichs, World Bank New HIV prevention intervention for adolescents in rural South African schools - Joseph Sevilla, Harvard School of Public Health Discussant: Key Questions, Issues and Scenarios Applicable to Policymakers and Decisions – Rose McCullough, Elizabeth Glaser Pediatric AIDS Foundation Session B for participants of Business and AIDS: Impact, Interventions and Benefits Chairs: Debbie Muirhead, Aurum Health Research, South Africa and Neeraj Mistry, Global Business Coalition on HIV/AIDS Facilitators: Marionette Holmes, Harvard School of Public Health and Jeffrey Sturchio, Merck & Co., Inc. Discussant: Key Questions, Issues and Scenarios Applicable to Policymakers and Decisions – John Bergstrom, The University of Georgia
3:00 – 3:15PM	Tea break
3:15 – 5:00PM	Policymaker Panel Session - Transforming Economic Analysis and Findings into Long-term Policy Planning: Key Issues, Questions and Scenarios Presented to Policymakers from Specialized Sessions of the Day Chair: Joy Phumaphi, World Health Organization • Joy Phumaphi, World Health Organization • Loeto Mazhani, Botswana Ministry of Health • Robert Oelrichs, World Bank • Dan Kress, Bill and Melinda Gates Foundation • Joseph O’Neill, Immune Response Corporation
5:00PM	Closing Remarks
7:00PM	Keynote Speaker: “AIDS: The Next 25 Years from Crisis to a Sustained Strategy” – Peter Piot, Joint United Nations Programme on HIV/AIDS Location: Harvard Club of Boston, 374 Commonwealth Avenue

Friday, September 15, 2006

7:30 – 8:30AM	Breakfast
8:30 – 8:45AM	Welcome-Housekeeping notes
8:45 – 10:15AM	Session 4: Translating Research into Practice: Methodological Issues Chairs: Sofia Gruskin, Harvard School of Public Health Facilitators: Robert Oelrichs, World Bank and Marionette Holmes, Harvard School of Public Health Are Community Benefits a Separate, Valuable (in economic evaluation terms) Benefit that Should be Included in Economic Evaluation? – Obinna Onwujekwe, Health Policy Research Group, Nigeria Methodological Issues: the ART of Extrapolation – Susan Cleary, Health Economics Unit, University of Cape Town, South Africa Modeling the Cost Effectiveness of Antiretroviral Treatment with Laboratory Monitoring in Resources-limited Settings – David Bishai, Johns Hopkins Bloomberg School of Public Health How Can We Calculate the "E" in "CEA"? – Lori Bollinger, Futures Institute The Use of Cost-utility Analysis and Preference Elicitation Methods in Resource Poor Settings – Antonieta Medina-Lara, Liverpool School of Tropical Medicine
10:15 – 10:30AM	Tea break
10:30AM – 12:00PM	Concurrent Sessions 5 and 6 Session 5: Broad Perspectives of Costing and Economic Impact Chairs: Markus Haacker, International Monetary Fund and William Rodriguez, Clinton Foundation and Harvard Medical School Facilitator: Steven Forsythe, Instituto Nacional de Salud Publica, Mexico Fiscal Policy Perspective of HIV/AIDS: Impact on Government Capacities – Markus Haacker, International Monetary Fund Economic Impact of HIV/AIDS in Botswana: Linkages between Macroeconomic, Sector and Household levels – Keith Jefferis, Econsult Botswana & Anthony Kinghorn, Health and Development Africa, South Africa Costing PEPFAR Initiatives – John Blandford, Global AIDS Program, Centers for Disease Control and Prevention Monitoring the Cost and Evaluating the Cost-effectiveness of HIV Services in Countries – Eduard Beck, Joint United Nations Programme on HIV/AIDS Decision Support Tools for Scale-up Planning – William Rodriguez, Clinton Foundation and Harvard Medical School Session 6: Scaling Up – How to Predict Costs? How to Calculate Costs? Chair: Stefano Bertozzi, Instituto Nacional de Salud Publica, Mexico Facilitator: Debbie Muirhead, Aurum Health Research, South Africa Ability to Generalize and Cost Estimation – Lilani Kumaranayake, London School of Hygiene and Tropical Medicine and Dalhousie University Main Determinants of Health Care Costs – Belkis Aracena, Instituto Nacional de Salud Publica, Mexico ART Costing: Namibia Experience – Tom Mbeeli, Resource Mobilization for National Development, Namibia Costing HIV Prevention in the Context of Scaling Up in India – Lalit Dandona, Administrative Staff College of India How Much Does It Cost to Provide Comprehensive Antiretroviral Treatment and Who Pays for It? – Gilbert Kombe, Abt Associates
12:00 – 1:00PM	Lunch
1:30 – 2:30PM	Concurrent Specialized Sessions: Framing Key Issues and Questions Session C for participants of Broad Perspectives of Costing and Economic Impact Chair: Anokhi Parikh, Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal, South Africa Facilitator: Robert Oelrichs, World Bank Discussant: Key Questions, Issues and Scenarios Applicable to Policymakers and Decisions – Marionette Holmes, Harvard School of Public Health Session D for participants of Scaling Up – How to Predict Costs? How to Calculate Costs? Chair and Facilitator: Debbie Muirhead, Aurum Health Research, South Africa Discussant: Key Questions, Issues and Scenarios Applicable to Policymakers and Decisions – Steven Forsythe, Instituto Nacional de Salud Publica, Mexico
2:30 – 2:45PM	Tea break
2:45 – 4:30PM	Policymaker Panel Session - Transforming Economic Analysis and Findings into Long-term Policy Planning: Key Issues, Questions and Scenarios Presented to Policymakers from Specialized Sessions of the Day Chairs: Peter Piot, Joint United Nations Programme on HIV/AIDS and Jim Kim, Harvard School of Public Health • Peter Piot, Joint United Nations Programme on HIV/AIDS • Jim Kim, Harvard School of Public Health • Diane Thompson, Elizabeth Glaser Pediatric AIDS Foundation • Yves Souteyrand, World Health Organization • Martha Ainsworth, World Bank
4:30PM	Closing Remarks and Plans for Publication

Shuttle bus schedule for the Wednesday evening dinner:
5:05 PM - Depart the Hotel Commonwealth, 500 Commonwealth Ave.
5:15 PM - Depart the Eliot Hotel, 370 Commonwealth Ave. to Boston Harbor Hotel

6:10 PM - Depart the Hotel Commonwealth, 500 Commonwealth Ave. Boston
6:20 PM - Depart the Eliot Hotel, 370 Commonwealth Ave., Boston to Boston Harbor Hotel

9:10 PM - Depart Boston Harbor Hotel
9:30 PM - Drop off at Hotel Commonwealth
9:40 PM - Drop off at Eliot Hotel

Want to be a part of this exciting and unique conference? We're looking for students who
would be interested in attending the conference as student rapporteurs.
Click here for more info.